The gastrin-releasing peptide receptor (GRPR), also known as bombesin receptor subtype 2, is a G-protein coupled receptor that is overexpressed in several solid cancers, such as breast, lung, and prostate cancer [2–4]. Here, GRPR is linked to prostate cancer.